TRIFARMA S.p.A. is an international and independent Group with the Mission to develop, manufacture and supply worldwide high quality APIs (Active Pharmaceutical Ingredients) to the global pharmaceutical industry.
To achieve our Vision, we affirm our values of Integrity, Respect for People, Customer Focus, Community, Innovation, Teamwork, Performance, Leadership, and Quality.
We are strongly committed in our effort to excel in QUALITY, both in Products and Service.
We make a point to be flexible and to promptly adapt ourselves to the continuously changing market scenarios.
We believe in continuous improvements: in our manufacturing processes, in our products quality, in our services.
We do share William A. Foster definition:
Quality is never an accident; it is always the result of high intention, sincere effort, intelligent direction and skillful execution; it represents the wise choice of many alternatives.
Thanks to its rather small size and its very active R&D and marketing teams, TRIFARMA is particularly fast in the decision-making process, which produces an extremely short period from lab-to-industrial scale development.
In order to further improve its presence on the globalized pharmaceutical marketplace, the two Italian API factories (formerly named Alchymars SpA and ICM Industria Chimica Milanese SpA) have merged into TRIFARMA SpA, thus creating a larger and industrially, commercially stronger organization.
TRIFARMA SpA (and its two incorporated factories) belong to the UK Group Gen.Phar.Pro Investments Ltd, which controls also the Indian factory Alchymars ICM SM Pvt Ltd (abbreviated as AIS) located in Chennai, India.
All the three factories are FDA approved.
On 27 - 30 July 2009 Ceriano Laghetto manufacturing site (formerly Alchymars) passed US FDA inspection, without issuance of 483 Form
On 18 - 21 May 2009 Ceriano Laghetto manufacturing site (formerly Alchymars) passed the inspection of the Italian Agency AIFA.
AIS (Alchymars ICM SM Pvt Ltd of Chennai/India) was inspected by the US FDA in April 2008 and classified as “Acceptable”.